Clinical Trial Update: Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating avelumab plus carboplatin-gemcitabine in metastatic urothelial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Associació per a la Recerca Oncologica, Spain | Conditions: Metastatic Urothelial Cancer | Phase 2 | Status: COMPLETED